The facility, which will be located in the NorthPoint Industrial Park, plans to manufacture the MetraClip, a transcatherter mitral valve repair system used to repair primary and secondary mitral regurgitation without open-heart surgery. The device has been implanted in more than 90,000 patients worldwide.
The Chicago-based company told the Indianapolis Business Journal it expects construction to start later this year and the facility to be fully operational by 2021.
The 120,000 square-foot facility will employ as many as 477 people by the end of 2024.
Read the full article here.
More articles on supply chain:
FDA warns of critical medical device shortages
UPS expanding healthcare warehouse, distribution network
FDA warns of blood leak risk with endografts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
